Moneycontrol
HomeNewscoronavirusWHO estimates 4.74 mn COVID-19 deaths in India in 2020, 2021; nearly 10 times the official toll

WHO estimates 4.74 mn COVID-19 deaths in India in 2020, 2021; nearly 10 times the official toll

As per the UN body, there were 14.9 mn excess deaths associated with COVID-19 by end-2021. The official count of deaths directly attributable to COVID-19 and reported to WHO in that period -- from January 2020 to the end of December 2021 -- is slightly more than 5.4 million. This means that the estimated toll is 9.5 million higher than the recorded fatalities.

May 05, 2022 / 21:18 IST
Story continues below Advertisement
Representative image

A World Health Organisation (WHO) report on excess COVID-19 mortality has estimated 4.74 million deaths for India in 2020 and 2021, nearly 10 times higher than the country’s official coronavirus toll of 4.84 lakh during the two years.

India, according to the report, had the highest excess COVID-19 deaths, followed by Russia and Indonesia.

Story continues below Advertisement

Globally, the world health body has estimated that almost three times more people have died of COVID-19 than the official data.

As per the UN body, there were 14.9 million excess deaths associated with COVID-19 by the end of 2021.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show